Market Place
Sourcing Support
FDA Grants Priority Review for Opdivo Plus Chemo in Lymphoma
11 Dec 2025 //
PHARMIWEB
BMS & BioNtech Unveil Promising Early Results for TNBC therapy
11 Dec 2025 //
INDPHARMAPOST
Bristol Myers Squibb Announces Dividend Increase
10 Dec 2025 //
BUSINESSWIRE
BMS`s Breyanzi Is First CAR-T Approved in US for Rare Lymphoma
06 Dec 2025 //
BUSINESSWIRE
Bristol Myers Squibb Continues ADEPT-2 Phase 3 Study In AD
03 Dec 2025 //
PHARMIWEB
Bristol Myers Squibb Showcases Hematology Pipeline At ASH 2025
01 Dec 2025 //
BUSINESSWIRE
Bristol Myers Must Face $6.7 B Lawsuit Over Delayed Cancer Drug
01 Dec 2025 //
REUTERS
BMS Joins Citi`s 2025 Global Healthcare Conference
26 Nov 2025 //
BUSINESSWIRE
Bristol Myers Squibb To Host Hematology-Focused Investor Event
24 Nov 2025 //
BUSINESSWIRE
BMS Gets EU Nod To Expand Breyanzi Use In Mantle Cell Lymphoma
24 Nov 2025 //
BUSINESSWIRE
Texas Sues Sanofi, BMS Over `Deceptive` Plavix Marketing
21 Nov 2025 //
FIERCE PHARMA
Bristol Myers Squibb Reveals Accepted Amounts & Pricing Terms
18 Nov 2025 //
BUSINESSWIRE
Update On Phase 3 Librexia ACS Trial
15 Nov 2025 //
BUSINESSWIRE
Evotec Secure BMS Milestone in Protein Degradation IND Acceptance
12 Nov 2025 //
PHARMIWEB
Sarah Cannon & Bristol Myers Squibb Expand Collaboration
12 Nov 2025 //
BUSINESSWIRE
BMS Boosts Cancer Trials With Sarah Cannon`s Platform
12 Nov 2025 //
FIERCE BIOTECH
Bristol Myers Squibb Prices €5B Senior Unsecured Notes
10 Nov 2025 //
INDPHARMAPOST
BMS Builds A `World Of Gratitude` To Honor HCPs In New PSA
10 Nov 2025 //
FIERCE PHARMA
Bristol Myers Squibb Prices €5 Billion Of Senior Unsecured Notes
05 Nov 2025 //
BUSINESS WIRE
Dispatch Bio Inks Clinical Supply Deal With Bristol Myers Squibb
04 Nov 2025 //
BUSINESSWIRE
Bristol Myers Squibb Presents Cardiovascular Portfolio Data
03 Nov 2025 //
BUSINESSWIRE
BMS Announces Cash Tender Offers To Purchase Notes
03 Nov 2025 //
BUSINESSWIRE
Bristol Myers Squibb Posts Q3 2025 Revenues $12.2 Billion
02 Nov 2025 //
INDPHARMAPOST
BMS Removes 2 Clinical Programs From Pipeline
30 Oct 2025 //
FIERCE BIOTECH
Bristol Myers Squibb Unveils Q3 2025 Financial Results
30 Oct 2025 //
BUSINESSWIRE
Cobenfy Delivers OK Debut Year As BMS Works To Ease Nerves
30 Oct 2025 //
FIERCE PHARMA
Enforcement Report - Week of October 29, 2025
29 Oct 2025 //
FDA
BMS, Cabaletta`s CAR T Therapy Shows Promise In Small Lupus Study
28 Oct 2025 //
BIOSPACE
Evotec Announces Preclinical Neuroscience Partnership with BMS
27 Oct 2025 //
PHARMIWEB
BMS Shows Sotyktu Efficacy In Psoriatic Arthritis & Lupus
27 Oct 2025 //
BUSINESS WIRE
Maplight Goes Public Via $250M IPO To Fund Cobenfy Competitor
27 Oct 2025 //
FIERCE BIOTECH
BMS Ph1 Breakfree-1 Data Show Promise for CD19 NEXT CAR T Therapy
25 Oct 2025 //
BUSINESSWIRE
Replimune`s Stock Spikes 100% On FDA Acceptance Of Resubmission
20 Oct 2025 //
FIERCE BIOTECH
Systimmune, Bristol Myers Squibb Unveil Global Phase I Results
17 Oct 2025 //
PR NEWSWIRE
Deck Bio And ReTrax Therapeutics Win 2025 BMS Golden Tickets
15 Oct 2025 //
PR NEWSWIRE
Insitro Extends Research Collab with BMS via ChemML Platform
14 Oct 2025 //
BUSINESSWIRE
Bristol Myers Squibb Highlights Oncology Innovations At ESMO 2025
14 Oct 2025 //
INDPHARMAPOST
Bristol Myers Squibb To Showcase Oncology Portfolio Progress
13 Oct 2025 //
BUSINESSWIRE
Bristol Myers Squibb launches Kopozgo (Mavacamten) in India
13 Oct 2025 //
EXPRESSPHARMA
BMS Cooks Up Schizophrenia Stigma-Busting Push With Gail Simmons
13 Oct 2025 //
FIERCE PHARMA
Ono`s BMS-Partnered IO Drug Passes Phase 2 Gastric Cancer Test
11 Oct 2025 //
FIERCE BIOTECH
BMS & Gail Launch Initiative to Reduce Schizophrenia Stigma
10 Oct 2025 //
BUSINESSWIRE
BMS Inks $1.5B Deal To Pull Orbital Into Its Sphere Of Influence
10 Oct 2025 //
PRESS RELEASE
Maplight Illuminates $262M IPO Plans To Fund Cobenfy Competitor
07 Oct 2025 //
FIERCE BIOTECH
BMS`s Anti-MTBR-Tau Receives Fast Track designation For Alzheimer
05 Oct 2025 //
INDPHARMAPOST
Bristol Myers`s BMS-986446 Receives FDA Fast Track Designation
01 Oct 2025 //
BUSINESSWIRE
Bristol Myers Squibb Secures FDA Fast Track For BMS-986446
01 Oct 2025 //
BUSINESSWIRE
Bms, Takeda Join Peers In Push To Improve AI By Pooling Data
01 Oct 2025 //
FIERCE BIOTECH
BMS Launches Patient Connect, Expands Access to Sotyktu
30 Sep 2025 //
INDPHARMAPOST
BMS Expands Patient Connect Platform With Eliquis And Sotyktu
25 Sep 2025 //
BUSINESSWIRE
BMS Puts Discounted Sotyktu At The Center Of Next DTC Platform
25 Sep 2025 //
FIERCE PHARMA
Systimmune To Showcase Data On Izalontamab Brengitecan & BL-M07D1
24 Sep 2025 //
PR NEWSWIRE
BMS Midtrial Endpoint Addition Secures Phase 3 Win in Myeloma
24 Sep 2025 //
FIERCE BIOTECH
BMS Will Charge Same Price In Uk As Its Does In Us For Cobenfy
22 Sep 2025 //
FIERCE PHARMA
Bristol Myers Squibb to Report Q3 2025 Results on Oct 30, 2025
19 Sep 2025 //
BUSINESSWIRE
Novo, BMS Layoffs Leave Over 500 Jobless in New Jersey
18 Sep 2025 //
BIOSPACE
6 Pharma Layoffs Could Eliminate Over 39,000 Jobs
18 Sep 2025 //
BIOSPACE
Bristol Myers Squibb Announces Dividend
17 Sep 2025 //
BUSINESSWIRE
NJ layoffs: Novo Nordisk dismisses 263, BMS cuts 282 workers
17 Sep 2025 //
FIERCE PHARMA
FDA approves Lupin`s Lenalidomide capsules
17 Sep 2025 //
INDPHARMAPOST
